York Instruments Ltd has acquired the MEG business of Elekta
York Instruments Ltd has acquired MEGIN, the MEG business of Elekta AB. Financial details have not been disclosed.
York Instruments is a company specializing in magnetic measurements and their healthcare applications. Using the very latest technologies and methodologies, York Instruments is focused on magnetoencephalography (MEG) and its ability to effectively assess neural networks. York Instruments' revolutionary MEG technology allows for earlier and improved diagnostic capability in relation to a variety of neurological diseases and conditions.
Magnetoencephalography (MEG) is the brain activity-mapping business of Elekta. MEG is a diagnostic functional neuroimaging technique for mapping brain activity. This can be applied in a clinical setting to find locations of abnormalities as well as in a research setting to simply measure brain activity. Elekta's MEG business, known as MEGIN, is a leading supplier of magnetoencephalography (MEG) technology, with more than 100 delivered MEG systems worldwide.
Elekta AB is a Swedish company that provides radiation therapy, radiosurgery, related equipment and clinical management for the treatment of cancer and brain disorders. The company employs 3,600 people around the world. Elekta is listed on NASDAQ Stockholm.
Oaklins Smith & Williamson, based in the UK, advised the buyer in this transaction.
![](/files/styles/hero_image/public/HEALTHCARE%20deal%204_0.jpg)
![](/api/deal-party-images/104282/deal-parties.png)
Sprechen Sie mit dem Deal-Team
Brian Livingston
Oaklins Evelyn Partners
Transaktionen
Leika Medical Equipments Ltd. has been acquired by Angus Capital
The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.
Mehr erfahrenPhen’X Technologies has sold a majority stake to Ciclad
The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.
Mehr erfahrenMedis Medical Imaging and GE HealthCare announce collaboration focused on non-invasive coronary assessments
Medis Medical Imaging Systems B.V., a leading cardiac imaging software company, have completed a strategic investment to further develop its revolutionary non-invasive cardiovascular imaging solution. The company has announced its collaboration with GE HealthCare (Nasdaq: GEHC), a global leader in medical technology, pharmaceutical diagnostics and innovation in digital solutions, to contribute to the advancement of precision care in the diagnosis and treatment of coronary artery disease (CAD).
Mehr erfahren